PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
54.58
ESG score 80-90% of Biotechnology median of 61.61. Martin Whitman would look for hidden ESG liabilities and regulatory risks.
49.62
Environmental score 80-90% of Biotechnology median of 56.94. Martin Whitman would look for hidden carbon liabilities and stranded asset risks.
57.51
Social score 80-90% of Biotechnology median of 64.31. Martin Whitman would look for hidden social liabilities and reputational risks.
56.60
Governance score 90-95% of Biotechnology median of 62.74. John Neff would demand higher returns to compensate for below-average governance oversight.